| HbA1C = < 7.0 (Gp.MF) | HbA1C 7.0 < (Gp.MP) | ||||
---|---|---|---|---|---|---|
= < 70y.o. | Insulin (-) | Insulin (+) | P | Insulin (-) | Insulin (+) | P |
 | Mean(SD) | Mean(SD) |  | Mean(SD) | Mean(SD) |  |
Duration of Diabetes (yrs) | 6.67 (7.50) | 12.18 (9.31) | 0.012* | 9.53(8.05) | 12.48 (8.15) | 0.011* |
   FBS (mg/dl) | 145.2 (44.4) | 158.2 (55) | 0.022* | 183.7(63.4) | 173.7(71) | 0.134 |
   SBP (mmHg) | 134.4 (15.5) | 133.4 (17.6) | 0.409 | 133.4(17.7) | 132.7 (18.3) | 0.893 |
   DBP (mmHg) | 77 (12.3) | 73.2 (14.8) | 0.011* | 76 (10.9) | 73.4(11) | 0.04* |
   TG (mg/dl) | 148.3(119.9) | 135.5 (65.3) | 0.844 | 154.1(111.6) | 141.9 (184) | 0.03* |
   HDL-C(mg/dl) | 55(14.2) | 57.2 (15.1) | 0.062 | 52.8(13.4) | 59.7(21.5) | 0.001** |
   LDL-C(mg/dl) | 116.3(31.9) | 110.5 (27.9) | 0.034* | 123.4(35.9) | 120.2(33.3) | 0.52 |
 | % | % | P | % | % | P |
Gender (Male/total) | 61.8 | 49.6 | 0.011* | 53.3 | 47.5 | 0.116 |
Anti-hyperlipidemic drugs | 53.9 | 49.3 | 0.131 | 52.7 | 58.6 | 0.477 |
statin | 41.4 | 39.0 | 0.122 | 48.5 | 45.7 | 0.444 |
Oral diabetic drugs | 44.4 | 10 | < 0.001** | 82.0 | 6.7 | < 0.001** |
sulfonylurea | 43.0 | 9.0 | < 0.001** | 79.4 | 8.6 | < 0.001** |
Anti-hypertensive drugs | 66.1 | 47.9 | 0.042* | 54.8 | 51.0 | 0.921 |
70 +y.o. | HbA1C = < 7.0 (Gp.OF) | HbA1C 7.0 < (Gp.OP) | ||||
 | Insulin (-) | Insulin (+) | P | Insulin (-) | Insulin (+) | P |
 | Mean(SD) | Mean(SD) |  | Mean(SD) | Mean(SD) |  |
Duration of Diabetes (yrs) | 10.83 (8.75) | 12.2 (9.67) | 0.12 | 10.67 (9.17) | 11.0 (9.50) | 0.43 |
   FBS (mg/dl) | 146.2 (47.1) | 159.1 (59) | 0.052 | 174.5 (70.5) | 181.7 (75.5) | 0.224 |
   SBP (mmHg) | 136.2 (16.4) | 135.7 (17) | 0.896 | 136.4 (15.9) | 136.2 (17) | 0.822 |
   DBP (mmHg) | 71.7 (11.2) | 70.4 (11.6) | 0.256 | 73.1 (11.3) | 73.1 (11.1) | 0.832 |
   TG (mg/dl) | 127.5 (73.4) | 124.3 (75.3) | 0.168 | 130.8 (75) | 124.6 (69.3) | 0.53 |
   HDL-C (mg/dl) | 55.1 (16) | 55 (17.3) | 0.953 | 54.7 (16.1) | 54.7 (16.5) | 0.888 |
   LDL-C (mg/dl) | 114.1 (29) | 112.3 (30.3) | 0.704 | 118.2 (30.7) | 117.8 (33.6) | 0.541 |
 | % | % | P | % | % | P |
Gender (Male/total) | 54 | 45.9 | 0.061 | 53.2 | 37.9 | 0.035* |
Anti-hyperlipidemic drugs | 50.2 | 46.0 | 0.140 | 46.7 | 50 | 0.307 |
statin | 43.9 | 40.2 | 0.003** | 43.3 | 42.5 | 0.167 |
Oral diabetic drugs | 62.6 | 18.5 | < 0.001** | 84.6 | 19.1 | < 0.001** |
sulfonylurea | 60.1 | 12.6 | < 0.001** | 79.4 | 8.0 | < 0.001** |
Anti-hypertensive drugs | 68.2 | 59.9 | 0.904 | 60.9 | 54.6 | 0.370 |